Formulation of a nanoemulsion for topical delivery of raloxifene
Objective: Raloxifene, a selective estrogen receptor modulator is used in the treatment of osteoporosis and invasive breast carcinoma in postmenopausal women. The effectiveness of oral therapy of raloxifene is not satisfactory because of its low water solubility, higher first pass metabolism and poo...
| Main Authors: | , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/58093/ http://irep.iium.edu.my/58093/1/MSPP%20cover%20page%20and%20abstract.pdf |